Following targeted routine antenatal anti-D prophylaxis, almost half of the pregnant women had undetectable anti-D prophylaxis at delivery. [PDF]
Introduction In September 2016, a nationwide targeted routine antenatal anti‐D prophylaxis program was implemented in Norway. The prophylaxis (anti‐D immunoglobulin) aims to cover the whole third trimester and is administered in gestational week 28 to ...
Sørensen K +8 more
europepmc +2 more sources
Monoclonal anti‐D for immunoprophylaxis [PDF]
Routine antenatal prophylaxis with anti‐D has become accepted as desirable, but concerns have been expressed about the adequacies of supply and safety of polyclonal anti‐D. Human monoclonal anti‐D has been produced using Epstein–Barr virus (EBV)‐transformed peripheral B cells, sometimes coupled with fusions to myeloma cell lines.
openaire +2 more sources
Monitoring and treatment of anti‐D in pregnancy
Prophylactic anti-D is a very safe and effective therapy for the suppression of anti-D immunization and thus prevention of haemolytic disease of the foetus and newborn. However, migration from countries with low health standards and substantial cuts in public health expenses have increased the incidence of anti-D immunization in many "developed ...
Bettelheim, D +35 more
openaire +5 more sources
Assay of anti-D using the Technicon AutoAnalyzer and the international standard anti-D typing serum [PDF]
A method is described for the automated quantitation of the anti-D content of sera. This procedure is far more reproducible than current manual techniques. The use of the International Standard anti-D typing serum in the calibration of a working standard enables results to be expressed in μg/ml of antibody protein.
W J, Judd, W J, Jenkins
openaire +2 more sources
The working out and introducing of anti-D-immunoprofylaxis program in the time of pregnancy in foreign countries and Russia are discussed, effectiveness of its long-term using on the base of the federal programs in developed European countries and America is analyzed; necessity and economic advisability of its introducing on the base of the federal and
openaire +2 more sources
A simple approach to confirm the presence of anti-D in sera with presumed anti-D+C specificity.
The G antigen belongs to the Rh system and is present on most D-positive red blood cells (RBC) and on most C-positive RBC1. For this reason, the true specificity of serum that apparently has anti-D and anti-C specificity when tested with the usual panels for the identification of irregular antibodies could correspond to one of the five possible ...
Fátima, Baía +9 more
openaire +2 more sources
Forty years of anti-D immunoprophylaxis.
As rightly underscored by Velati in his article published in this issue of Blood Transfusion1, the history of haemolytic disease of the newborn due to foetal-maternal incompatibility for the D antigen, universally and succinctly known as Rh HDN, bears witness to one of the most brilliant successes achieved in Medicine.
openaire +2 more sources
Asian-type DEL (RHD*DEL1) with an allo-anti-D: A paradoxical observation in a healthy multiparous woman. [PDF]
Ohto H +6 more
europepmc +1 more source
Intramuscular Anti-D treatment for immune thrombocytopenia: A single centre experience. [PDF]
Lakhwani S +7 more
europepmc +1 more source
Anti-G with Concomitant Anti-D and Anti-C in a Pre-natal Patient, in India: Multi-disciplinary Approach to Diagnosis and Management. [PDF]
Silwal P +4 more
europepmc +1 more source

